Susquehanna International Group, LLP Protalix Bio Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2024

Call Options

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	SELL	$1.22 - $1.82 $55,144 - $82,264	-45,200 Reduced 61.92%	27,800 $35,000
Q4 2023 Feb 14, 2024	SELL	$1.34 - $1.85 $75,040 - $103,600	-56,000 Reduced 43.41%	73,000 $129,000
Q3 2023 Nov 14, 2023	SELL	$1.49 - $2.02 $396,787 - $537,926	-266,300 Reduced 67.37%	129,000 $214,000
Q2 2023 Aug 11, 2023	SELL	$2.0 - $3.36 $121,000 - $203,280	-60,500 Reduced 13.27%	395,300 $790,000
Q1 2023 May 16, 2023	BUY	$1.37 - $2.16 $139,329 - $219,672	101,700 Added 28.72%	455,800 $957,000

Q4 2022 Feb 14, 2023	BUY	$1.02 - $1.37 $106,794 - $143,439	104,700 Added 41.98%	354,100 $485,000
Q3 2022 Nov 14, 2022	SELL	$1.03 - $1.24 $135,754 - $163,432	-131,800 Reduced 34.58%	249,400 $259,000
Q2 2022 Aug 15, 2022	BUY	$1.02 - $1.56 $126,888 - $194,064	124,400 Added 48.44%	381,200 $416,000
Q1 2022 May 16, 2022	BUY	$0.81 - $1.17 $178,119 - $257,282	219,900 Added 595.93%	256,800 $272,000
Q4 2021 Feb 14, 2022	SELL	$0.81 - $1.33 $163,944 - $269,192	-202,400 Reduced 84.58%	36,900 $31,000
Q3 2021 Nov 15, 2021	SELL	$1.31 - $1.87 $359,857 - $513,689	-274,700 Reduced 53.44%	239,300 $318,000
Q2 2021 Aug 11, 2021	BUY	$1.86 - $6.22 $820,632 - $2.74 Million	441,200 Added 606.04%	514,000 $982,000
Q1 2021 May 17, 2021	BUY	$3.58 - $6.45 $171,840 - $309,600	48,000 Added 193.55%	72,800 $325,000
Q4 2020 Feb 16, 2021	SELL	$3.15 - $3.98 $17,010 - $21,492	-5,400 Reduced 17.88%	24,800 $90,000
Q3 2020 Nov 16, 2020	SELL	$3.37 - $3.93 $457,309 - $533,301	-135,700 Reduced 81.8%	30,200 $117,000
Q2 2020 Aug 14, 2020	BUY	$2.19 - $4.5 $305,943 - $628,650	139,700 Added 533.21%	165,900 $629,000
Q1 2020 May 15, 2020	BUY	$2.1 - $4.61 $55,020 - $120,782	26,200 New	26,200 $62,000

Others Institutions Holding PLX

# of Institutions

Shares Held

9.27M

Call Options Held

40.6K

Put Options Held

10.1K

View Full List

About Protalix BioTherapeutics, Inc.

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $53.7M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

More about PLX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account